Twenty-six week carcinogenicity study of ampicillin in CB6F1-TgrasH2 mice. 2002

Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
Safety Research Laboratory, Tanabe Seiyaku Co., Ltd., 3-16-89 Kashima, Yodogawa-ku, Osaka 532-8505, Japan.

As a part of the ILSI-HESI Alternative to Carcinogenicity Testing (ACT) program, we performed a 26-week carcinogenetic study of nonmutagenic drug, ampicillin (ABPC) in Tg-rasH2 mice. ABPC was given to Tg-rasH2 mice (0, 350, 1000, 3000 mg/kg, p.o.) and Non-Tg mice (0, 3000 mg/kg, p.o.) daily for 26 weeks. As a positive control, a single dose of MNU was administered once to Tg-rasH2 mice (75 mg/kg, i.p.). In this study, Tg-rasH2 mice did not demonstrate any increases in tumor development in response to ABPC. Thus, ABPC had no carcinogenicity in the 26-week carcinogenesis study in Tg-rasH2 mice or in a 2-year carcinogenesis study in B6C3F1 mice.

UI MeSH Term Description Entries
D008136 Longevity The normal length of time of an organism's life. Length of Life,Life Span,Lifespan,Life Spans,Lifespans
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D011905 Genes, ras Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. Ha-ras Genes,Ki-ras Genes,N-ras Genes,c-Ha-ras Genes,c-Ki-ras Genes,c-N-ras Genes,ras Genes,v-Ha-ras Genes,v-Ki-ras Genes,H-ras Genes,H-ras Oncogenes,Ha-ras Oncogenes,K-ras Genes,K-ras Oncogenes,Ki-ras Oncogenes,N-ras Oncogenes,c-H-ras Genes,c-H-ras Proto-Oncogenes,c-Ha-ras Proto-Oncogenes,c-K-ras Genes,c-K-ras Proto-Oncogenes,c-Ki-ras Proto-Oncogenes,c-N-ras Proto-Oncogenes,ras Oncogene,v-H-ras Genes,v-H-ras Oncogenes,v-Ha-ras Oncogenes,v-K-ras Genes,v-K-ras Oncogenes,v-Ki-ras Oncogenes,Gene, Ha-ras,Gene, Ki-ras,Gene, v-Ha-ras,Gene, v-Ki-ras,Genes, Ha-ras,Genes, Ki-ras,Genes, N-ras,Genes, v-Ha-ras,Genes, v-Ki-ras,H ras Genes,H ras Oncogenes,H-ras Gene,H-ras Oncogene,Ha ras Genes,Ha ras Oncogenes,Ha-ras Gene,Ha-ras Oncogene,K ras Genes,K ras Oncogenes,K-ras Gene,K-ras Oncogene,Ki ras Genes,Ki ras Oncogenes,Ki-ras Gene,Ki-ras Oncogene,N ras Genes,N ras Oncogenes,N-ras Gene,N-ras Oncogene,c H ras Genes,c H ras Proto Oncogenes,c Ha ras Genes,c Ha ras Proto Oncogenes,c K ras Genes,c K ras Proto Oncogenes,c Ki ras Genes,c Ki ras Proto Oncogenes,c N ras Genes,c N ras Proto Oncogenes,c-H-ras Gene,c-H-ras Proto-Oncogene,c-Ha-ras Gene,c-Ha-ras Proto-Oncogene,c-K-ras Gene,c-K-ras Proto-Oncogene,c-Ki-ras Gene,c-Ki-ras Proto-Oncogene,c-N-ras Gene,c-N-ras Proto-Oncogene,ras Gene,ras Oncogenes,v H ras Genes,v H ras Oncogenes,v Ha ras Genes,v Ha ras Oncogenes,v K ras Genes,v K ras Oncogenes,v Ki ras Genes,v Ki ras Oncogenes,v-H-ras Gene,v-H-ras Oncogene,v-Ha-ras Gene,v-Ha-ras Oncogene,v-K-ras Gene,v-K-ras Oncogene,v-Ki-ras Gene,v-Ki-ras Oncogene
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
May 2001, The Journal of toxicological sciences,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
January 2002, Toxicologic pathology,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
January 2017, Archives of toxicology,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
December 2006, The Journal of toxicological sciences,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
January 2022, Toxicologic pathology,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
January 2011, Archives of toxicology,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
October 2007, The Journal of toxicological sciences,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
December 1994, Arzneimittel-Forschung,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
December 1994, Arzneimittel-Forschung,
Tamiko Adachi, and Yuki Kuwamura, and Toshihisa Fujiwara, and Noriaki Tanimoto, and Tomonari Nishimura, and Atsushi Koguchi, and Kinji Kobayashi, and Yoshifumi Sasaki, and Chisato Yamaguchi, and Tatsuya Honda, and Kazutaka Kawashima, and Hirofumi Yuasa, and Takaaki Yamamura, and Toshihide Inui
January 2003, Toxicologic pathology,
Copied contents to your clipboard!